Outlook Therapeutics (OTLK) Shares Outstanding (Entity) (2015 - 2026)
Outlook Therapeutics' Shares Outstanding (Entity) was 136.74 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 214.5% from 43.48 million a year earlier and up 67.1% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Shares Outstanding (Entity) at Outlook Therapeutics came in at 34.8 million, up 87.6% from FY2024.
- Shares Outstanding (Entity) has now increased for ten consecutive fiscal years, with a five-year compound annual growth rate of 57.2% (FY2020 to FY2025).
- In earlier fiscal years, Shares Outstanding (Entity) was 18.55 million in FY2024 (+42.5%), 13.01 million in FY2023 (+14.5%), 11.37 million in FY2022 (+28.8%) and 8.82 million in FY2021 (+143.2%).
- The fiscal Q3 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q2 2015.
- Compared with a year earlier, Shares Outstanding (Entity) has increased for 42 straight quarters, with growth averaging 120.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 1.4% (fiscal Q1 2024) to 214.5% (fiscal Q3 2026).
- Per Business Quant data, OTLK's Shares Outstanding (Entity) in the three fiscal quarters before Q3 2026 was 81.84 million (Q2 2026), 64.56 million (Q1 2026) and 34.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 | 136.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.74 Mn |
| Mar 31, 2026 | 81.84 Mn |
| Dec 31, 2025 | 64.56 Mn |
| Sep 30, 2025 | 34.80 Mn |
| Jun 30, 2025 | 43.48 Mn |
| Mar 31, 2025 | 32.91 Mn |
| Dec 31, 2024 | 24.91 Mn |
| Sep 30, 2024 | 18.55 Mn |
| Jun 30, 2024 | 23.41 Mn |
| Mar 31, 2024 | 14.27 Mn |
| Dec 31, 2023 | 13.01 Mn |
| Sep 30, 2023 | 13.01 Mn |
| Jun 30, 2023 | 12.94 Mn |
| Mar 31, 2023 | 12.83 Mn |
| Dec 31, 2022 | 12.83 Mn |
| Sep 30, 2022 | 11.37 Mn |
| Jun 30, 2022 | 11.30 Mn |
| Mar 31, 2022 | 11.29 Mn |
| Dec 31, 2021 | 11.21 Mn |
| Sep 30, 2021 | 8.82 Mn |
API Access
Outlook Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();